Interleukin-5 messenger RNA expression in peripheral blood CD4+ cells in asthma

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 6, 1996, Pages 1320-1328

  Lai, Christopher K W ^a   Ho, Alice S S ^a   Chan, Christopher H S ^a   Tang, Janet ^a   Leung, Joseph C K ^a   Lai, Kar N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

asthma; corticosteroids; Cytokines; eosinophil cationic protein; eosinophils; IL 5; T lymphocytes

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 5; MESSENGER RNA;

ADULT; ARTICLE; ASTHMA; CELL PROLIFERATION; CELL SURVIVAL; EFFECTOR CELL; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VENOUS BLOOD;

EID: 0030003887     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70201-4     Document Type: Article

References (39)

1. Djukanovic R, Wilson JW, Britten KM, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
2. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-36.
3. Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993; 23(suppl 2):3-7.
4. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
5. Holgate S. Mediator and cytokine mechanisms in asthma. Thorax 1993;48:103-9.
6. Robinson DS. Interleukin-5, eosinophils and bronchial hyperreactivity. Clin Exp Allergy 1993;23:1-3.
7. Lai CKW, Chan CHS, Leung JCK, Lai KN. Serum concentration of soluble interleukin 2 receptors in asthma: correlation with disease activity. Chest 1993;103:782-6.
8. + T cells after activation with phorbol myristate acetate and phytohaemagglutinin. Clin Exp Immunol 1992; 90:147-53.
9. Brenner CA, Tam AW, Nelson PA, et al. Message amplification phenotyping (MAPPing): a technique to simultaneously measure mRNAs from small numbers of cells. BioTechniques 1989;7:1096-103.
10. Siebert P, editor. RT-PCR: methods and applications book. Palo Alto: Clontech Laboratories, Inc., 1991.
11. Campbell HD, Tucker WQJ, Hort Y, et al. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5) Proc Natl Acad Sci USA 1987;84:6629-33.
12. Peterson CGB, Enander I, Nystrand J, et al. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-7.
13. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988;1:1129-31.
14. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease activity and atopic status. Am Rev Respir Dis 1990;141:970-7.
15. Brown PH, Crompton GK, Greening AP. Proinflammatory cytokines in acute asthma. Lancet 1991;338:590-3.
16. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
17. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing mRNA for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
18. + T cells and increased IL-4, IL-5, and GM-CSF mRNA positive cells in bronchoalveolar lavage fluid (BAL) 24 hours after allergen inhalation challenge of atopic asthmatic patients. J Allergy Clin Immunol 1993; 92:313-24.
19. Walker C, Bode E, Boer L, et al. Allergic and non-allergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
20. Corrigan CJ, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-7.
21. Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay AB, Corrigan CJ. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax 1994;49:1231-3.
22. Piccini MP, Macchia D, Parronchi P, et al. Human bone marrow non-B, non-T cells producing IL-4 in response to cross-linkage of FCε and FOγ receptors. Proc Natl Acad Sci USA 1991;88:8656-60.
23. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin-5 and granulocyte macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
24. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-9.
25. Lee HJ, Koyano-Nakagawa N, Naito Y, et al. cAMP activates IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J Immunol 1993;151:6135-42.
26. Kelly EAB, Huffman DP, Busse WW, Jariour NN. Differential regulation of TH1- and TH2-associated cytokines by the β-adrenergic agonist, albuterol [abstract]. Am J Respir Crit Care Med 1995;151:A778.
27. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993;306:1034-7.
28. Heino M. Regularly inhaled β-agonists with steroids are not harmful in stable asthma. J Allergy Clin Immunol 1994;93:80-4.
29. Chapman KR, Kesten S, Szalai JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994;343: 1379-82.
30. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
31. Roberts JA, Bradding P, Walls AF, et al. The influence of salmeterol xinafoate on mucosal inflammation in asthma [abstract]. Am Rev Respir Dis 1992;145:A418.
32. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-11.
33. Cousins DJ, Staynov DZ, Lee TH. Regulation of interleukin-5 and granulocyte-macrophage colony-stimulating factor expression. Am J Respir Crit Care Med 1994;150:S50-S53.
34. Doi S, Gemou-Engesaeth V, Kay AB, Corrigan CJ. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin Exp Allergy 1994;24:854-67.
35. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
36. Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-42.
37. Walsh GM, Hartnell A, Wardlaw AJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
38. Holgate ST. Surrogate markers for monitoring inflammation in asthma-discussion section. Clin Exp Allergy 1993; 23(suppl 2):15-22.
39. Lai CKW, Ho SS, Chan CHS, Lai KN. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) messenger (m) RNA expression in circulating CD4+ cells in asthma [Abstract]. J Allergy Clin Immunol 1995;95:276.